Current UK professional guidance emphasises: Patients should inform their surgical team and anaesthetist that they are taking a GLP-1 medication as soon as surgery is planned Healthcare professionals should specifically ask about GLP-1 use during preoperative assessment, as patients may not recognise these medications as relevant to their surgery The decision to continue or pause GLP-1 therapy should be made on an individual risk-based assessment , considering the type of surgery, the specific GLP-1 agent, dose escalation status, presence of gastrointestinal symptoms, and the patient's clinical circumstances Many patients can safely continue GLP-1 medications perioperatively with appropriate precautions, while those at higher risk may benefit from temporary cessation The Summary of Product Characteristics (SmPC) for GLP-1 medications notes the delayed gastric emptying effect, which anaesthetists consider when planning perioperative care
doi: References Kieffer, T
These beneficial effects were suggested to be particularly helpful in other IR-associated disorders beyond T2D, such as individuals with NAFLD/NASH and PCOS [65, 67, 68]
Common syringe reading mistakes The number one mistake is parallax error
Its glucose-dependent insulin-stimulating mechanism reduces but does not eliminate the risk of hypoglycaemia, particularly in monotherapy